Get started Log in

VCYT — Veracyte Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Market Cap
$3.57bn
Enterprise Value
$3.08bn
Revenue
$517.15m

Brief: Veracyte Inc - New Data To Be Presented At Asco 2022 Showing Immunoscore IC Assay's Ability To Identify Patients With Nsclc Who May Benefit From Icis
27/05/2022 24:53
Veracyte Inc reports results for the quarter ended in March - Earnings Summary
04/05/2022 04:08
Brief: Veracyte Announces First Quarter 2022 Financial Results
03/05/2022 21:36
Veracyte Inc expected to post a loss of 24 cents a share - Earnings Preview
29/04/2022 21:51
Veracyte Inc reports results for the quarter ended in December - Earnings Summary
01/03/2022 24:06
Brief: Veracyte Announces Fourth Quarter And Full-Year 2021 Financial Results
28/02/2022 22:32
Brief: Veracyte Appoints Annie Mcguire As General Counsel
28/02/2022 13:51
Veracyte Inc expected to post a loss of 16 cents a share - Earnings Preview
25/02/2022 22:40
Brief: Veracyte Says New Data Validate Clinical Utility Of Co’S Decipher Prostate Genomic Classifier To Help Guide Therapy In Men With Intermediate-Risk Prostate Cancer
15/02/2022 24:36
Brief: Veracyte's Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment For Patients With Early-Stage Lung Cancer
24/01/2022 14:52
Brief: Veracyte Announces Publication Of Data On Clinical Utility Of Envisia Genomic Classifier
14/12/2021 21:15
Brief: Veracyte Announces Third Quarter 2021 Financial Results
09/11/2021 22:04
Veracyte Inc reports results for the quarter ended in September - Earnings Summary
09/11/2021 22:03
Brief: New Data Demonstrate Clinical Utility Of Veracyte’S Decipher Prostate Genomic Classifier In Tailoring Treatment For Prostate Cancer Patients Experiencing Progression After Surgery
26/10/2021 14:27
Brief: Veracyte Says Co's Decipher Bladder Test Accurately Identifies Tumors Most Likely To Respond To Chemotherapy
13/10/2021 14:43
Brief: Veracyte Inc Announces New Expanded Data At Chest Underscoring Percepta Nasal Swab Test’S Ability
11/10/2021 13:16
Brief: Veracyte Announces That New NCCN Guidelines Uniquely Recommend Use Of Decipher Prostate Genomic Test Score To Guide Specific Treatment For Men Following Radical Prostatectomy
14/09/2021 21:10
Veracyte Inc reports results for the quarter ended in June - Earnings Summary
30/07/2021 04:13
Brief: Veracyte Announces Second Quarter 2021 Financial Results
29/07/2021 21:41
Veracyte Inc expected to post a loss of 25 cents a share - Earnings Preview
27/07/2021 22:33